Chemical Compound

(3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-6-{[(aminocarbonyl)amino]methylidene}-3-[(4R,6S)-2-amino-6-hydroxy-3,4,5,6-tetrahydropyrimidin-4-yl]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-15-yl]hexanamide

CAS Registry Number 32988-50-4
返回搜索 申请报价
(3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-6-{[(aminocarbonyl)amino]methylidene}-3-[(4R,6S)-2-amino-6-hydroxy-3,4,5,6-tetrahydropyrimidin-4-yl]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-15-yl]hexanamide 结构式
Primary record

(3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-6-{[(aminocarbonyl)amino]methylidene}-3-[(4R,6S)-2-amino-6-hydroxy-3,4,5,6-tetrahydropyrimidin-4-yl]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-15-yl]hexanamide

库存
5,576 克
纯度
99.4 %
CAS
32988-50-4

化合物标识与属性

CAS
32988-50-4
PubChem CID
135398671
SMILES
C1[C@@H](N=C(N[C@H]1O)N)[C@H]2C(=O)NC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N/C(=C\NC(=O)N)/C(=O)N2)CO)CO)NC(=O)C[C@H](CCCN)N
Canonical SMILES
NCCC[C@H](N)CC(=O)N[C@H]1CNC(=O)[C@H]([C@H]2C[C@H](O)NC(N)=N2)NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC1=O

名称与同义词

  • VIOMYCIN
  • Celiomycin
  • Florimycin
  • Tuberactinomycin B
  • Vioactane
  • Viomycinum
  • Viomicina
  • Viomycine
  • Vinacetin A
  • Floromycin
  • Viocin
  • Viomicin
  • Vinactane
  • Viomycins
  • Viomycin-sulfat
  • Viocin sulfate
  • Viomycin [INN]
  • Florimycin sulfate
  • Viomicina [Italian]
  • Celicomycin-sulfate
  • Viomycin (VM)
  • Solfato di viomicina
  • Viomycin [INN:BAN]
  • Viomycine [INN-French]
  • Viomycinum [INN-Latin]
  • Viomicina [INN-Spanish]
  • VIOMYCIN SULFATE
  • Viomycin sulfate [USP]
  • AC1MI3VU
  • RefChem:194382
  • Viomycin-sulfat [German]
  • Viomycin, sulfate (salt)
  • 32988-50-4
  • DTXSID0023741
  • VIOMYCIN [WHO-DD]
  • UNII-YVU35998K5
  • UNII-LKO141R05V
  • YVU35998K5
  • CHEBI:15782
  • DTXCID303741
  • Solfato di viomicina [Italian]
  • TUBERACTINOMYCIN B [MI]
  • CHEMBL3085436
  • EINECS 251-323-0
  • GXFAIFRPOKBQRV-GHXCTMGLSA-N
  • HY-A0155
  • C25H43N13O10.xH2O4S
  • BBF-03426
  • C25H43N13O10
  • EX-A11481
  • CID3037981
  • DB06827
  • C25-H43-N13-O10
  • CID:135398671
  • SID:134224802
  • AB00514055
  • C25-H43-N13-O10.x-H2-O4-S
  • C01540
  • D014756
  • (3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4S,6R)-2-amino-4-hydroxy-1,4,5,6-tetrahydropyrimidin-6-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]hexanamide
  • (3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4R,6S)-2-amino-6-hydroxy-1,4,5,6-tetrahydropyrimidin-4-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]hexanamide
  • (3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-6-[(carbamoylamino)methylene]-3-[(4R,6S)-6-hydroxy-2-iminohexahydropyrimidin-4-yl]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-15-yl]hexanamide
  • 37883-00-4
  • (3S)-3,6-diamino-N-((3S,6Z,9S,12S,15S)-3-((4R,6S)-2-amino-6-hydroxy-1,4,5,6-tetrahydropyrimidin-4-yl)-6-((carbamoylamino)methylidene)-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl)hexanamide
  • (3S)-3,6-diamino-N-((3S,6Z,9S,12S,15S)-3-((4R,6S)-2-amino-6-hydroxy-3,4,5,6-tetrahydropyrimidin-4-yl)-6-((carbamoylamino)methylidene)-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl)hexanamide
  • (3S)-3,6-diamino-N-((3S,6Z,9S,12S,15S)-3-((4S,6R)-2-amino-4-hydroxy-1,4,5,6-tetrahydropyrimidin-6-yl)-6-((carbamoylamino)methylidene)-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl)hexanamide
  • (3S)-3,6-diamino-N-((3S,6Z,9S,12S,15S)-6-((carbamoylamino)methylene)-3-((4R,6S)-6-hydroxy-2-iminohexahydropyrimidin-4-yl)-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-15-yl)hexanamide
  • (3S)-3,6-Diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4R,6S)-2-amino-6-hydroxy-3,4,5,6-tetrahydropyrimidin-4-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-15-yl]hexanamide
  • (3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4R,6S)-6-hydroxy-2-imino-hexahydropyrimidin-4-yl]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-6-(ureidomethylene)-1,4,7,10,13-pentazacyclohexadec-15-yl]hexanamide
  • (3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-6-{[(aminocarbonyl)amino]methylidene}-3-[(4R,6S)-2-amino-6-hydroxy-3,4,5,6-tetrahydropyrimidin-4-yl]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-15-yl]hexanamide
  • (S)-3,6-Diamino-N-((3S,9S,12S,15S,Z)3((2R,4S)-6-amino-4-hydroxy-1,2,3,4-tetrahydropyridin-2-yl)-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-6-(ureidomethylene)-1,4,7,10,13-pentaazacyclohexadecan-15-yl)hexanamide disulfate
  • 251-323-0
  • GLYCINE, 3-AMINO-N-((3S)-3,6-DIAMINO-1-OXOHEXYL)-L-ALANYL-L-SERYL-L-SERYL-(2Z)-3-((AMINOCARBONYL)AMINO)-2,3-DIDEHYDROALANYL-2-((4R,6S)-2-AMINO-1,4,5,6-TETRAHYDRO-6-HYDROXY-4-PYRIMIDINYL)-, (5->13)-LACTAM, (2S)-
  • VIO